Engineers at the Massachusetts Institute of Technology (MIT) have developed a new type of customizable vaccine that could work against Ebola and other disease outbreaks, and could be deployed faste

Congenital sodium diarrhoea (CSD) refers to a form of secretory diarrhoea with intrauterine onset and high faecal losses of sodium without congenital malformations. The molecular basis for CSD remains unknown. We clinically characterised a cohort of infants with CSD and set out to identify disease-causing mutations by genome-wide genetic testing.
 
 
 

South Africa has more people living with HIV, an estimated 6.6 million, than any country in the world. About half are now receiving antiretroviral (ARV) treatment, which has greatly stressed the country's health care system. Now, South Africa plans to encourage all infected people to learn their status and start treatment as part of the drive to end its epidemic. The cornerstone of the campaign is the fact that HIV-infected people who take ARVs and fully suppress their virus rarely transmit to others.

Two Zika vaccine candidates have shown promising results in pre-clinical trials, scientists have announced.

A single dose of an experimental vaccine can protect mice against the Zika virus, raising renewed hope of a vaccine for humans, say scientists.

Australian researchers believe they've cracked the code which could lead to keeping the dreaded herpes virus, which causes cold sores, at bay for good.

About 5.7 million Americans have heart failure, half of whom will die from the disease within 5 years, according to the Centers for Disease Control and Prevention (CDC).

A new small study showed that a certain human antibody, which already has the potential to protect people against Human Immunodeficiency Virus, can help suppress viral rebound in HIV-positive patie

Zika virus is a member of the flavivirus genus that had not been associated with severe disease in humans until the recent outbreaks, when it was linked to microcephaly in newborns in Brazil and to Guillain-Barré syndrome in adults in French Polynesia.

The first Phase-1 human clinical trial of a vaccine for the Zika virus is set to begin in the coming weeks, with the U.S. Food and Drug Administration (FDA) green-lighting it.

Pages